Papers
2
Total Citations
8
H-Index
2
About
Jun Itami is a leading figure in radiation oncology, with a specialized focus on ultrahypofractionated treatments for prostate cancer and stereotactic body radiotherapy (SBRT) for complex lung tumors. His major contributions lie in comparative treatment planning, where he has systematically evaluated the dosimetric advantages of high-dose-rate brachytherapy (HDR-BT) against robotic and conventional SBRT for prostate cancer. His 2023 study, which has garnered 6 citations, provides critical insights into optimizing dose distribution and minimizing toxicity in ultrahypofractionated regimens. Additionally, his 2009 work on SBRT for lung tumors at the pulmonary hilum (2 citations) demonstrates his early exploration of challenging anatomical sites, paving the way for safer and more effective non-invasive interventions. Itami’s research is instrumental in refining clinical protocols, offering evidence-based guidance for radiation oncologists seeking to balance tumor control with organ-at-risk sparing. His work continues to shape modern radiotherapy paradigms, making him a respected voice in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2Stereotactic Body Radiotherapy for Lung Tumors at the Pulmonary Hilum2 citations · 2009